One day after tumour inoculation allocated mice received a daily intraperitoneal injection with ALK 4/5 inhibitors SB431542 (SB, 10 mg/kg) or GW788388 (GW IP, 10 mg/kg). The gene discussed is ALK; the disease is neoplasm.